23 Jul 2012
Prof Richard Sullivan talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about the value of cancer care and society.
?
The framing for value cancer care and society is not soley based on finances, but on the principles of how to deliver care, treatment or diagnostic, equally to all patients.
?
Prof Sullivan stresses that good care must be put into context for all non-communicable diseases in each country, as different countries have different burdens with other diseases.?The proportion of money going into care does not always correlate to the outcomes because organisations framing the policies and their attitudes are just as important as funding.
23 Jul 2012
Dr Rajendra Badwe talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about implementation of standard guidelines and making cancer care more cost effective in India.
?
Guidelines need to translate across borders and be tailored to specific infrastructures. Due to financial difficulties in India, cancer care is made affordable by not using recently developed drugs and investigating further uses of older drugs.
?
Dr Badwe also discusses screening in India and the need for solid guidelines before serious implementation of programmes.?
23 Jul 2012
Dr Philippe Autier talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about the efficacy of screening programmes.
?
Also mentioned is evidence for new methods for the reorganising of the management of health care and correcting the ineffective methods of breast cancer screening.
23 Jul 2012
Prof Peter Boyle, chair of the 2012 National Cancer Institute Directors Meeting in Lyon, talks to ecancer about the importance and highlights of this meeting.
?
Prof Boyle discusses on the need for collaboration between institutes, screening and creating opportunities for training in developing countries.
?
23 Jul 2012
Dr Paul Ndom talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about NGO activists, cancer care in Cameroon and the Chemotherapy Solidarity Association (SOCHIMIO).
?
The growing problem of cancer diagnosis in Cameroon, as in other African countries, is the main concern with a lack of facilities and trained staff.
?
Previously, funding was given only to the prevention of infectious disease, but now with the rise of cancer cases, funding for prevention research has begun in Cameroon. In Cameroon, many patients never see a doctor outside of their village and can only be seen by a physician when the can travel to them, making consistent treatment very difficulty.
?
To correct this problem Dr Ndom stress the need for awareness and action on the part of the government and collaboration with other institutes.
23 Jul 2012
Prof Kurt Zatloukal talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about preclinical work, biobanks and the systematic investigation of human biological samples.
?
Research using biological samples requires a complex legal framework and to combat this biobanks are needed to create international collaboration with a systematic approach.
?
Prof Zatloukal stresses the need for a common framework for bench scientists and clinicians can be meet in this interdisciplinary effort.?
21 Jul 2012
Nancy Brinker talks to ecancer.tv about the work her organisation is doing to decrease the level of geographic and economic heterogeneity in cancer treatment standards.
?
The World Breast Cancer Report which was presented at the National Cancer Institute Directors (NCID) meeting in Lyon has uncovered significant disparities between higher income and lower income countries and between rich and poor in high-income countries in all aspects of breast cancer diagnosis, treatment and outcome.
?
Ms Brinker explains that breast cancer is becoming an increasing problem in less economically developed countries and stresses the importance of early detection and the need for more patient support and education.
20 Jul 2012
Jean Mossman talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about her talk on the importance of the patient?s perspective in cancer care.
?
As the patient receives the treatment, their opinion should be valued; however, the regulatory process between efficacy and safety often creates problems. In some cases, patients with advanced stage cancer will not take safety into consideration as much as efficacy.
?
Very often regulators put too much emphasis on the safety of a drug, which ultimately slows the decision process.
?
Mossman believes that a method needs to be developed that can determine ?the right timing for the right treatment and the right patient?.?
20 Jul 2012
Prof Hilal al Sayer talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about paediatric palliative care and the opening of the Bayt Abdullah Children?s Hospital in Kuwait.
?
Until recently there has been little or no palliative treatment or hollistic care for children or adult patients in Kuwait.
?
Prof al Sayer began work on creating the Bayt Abdullah Children?s Hospital after a personal experience with a patient and their family. Now the hospital, which opened this year, is one of the largest in the area for palliative care.
?
Treating patients both at the hospital and in their own homes, Prof al Sayer advises doctors on the importance of how to discuss end of life treatment with the family and the need to do so.
20 Jul 2012
Dr David Zardize talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about the state of cancer prevention and screening in Russia.
?
On the whole, cancer is declining in Russia, especially smoking and alcohol related cancers. This reduction comes from a large effort to change the public perception of smoking and drinking.
?
In Russia, many people are not aware of the extremely detrimental side effects of drinking and smoking and while the numbers are improving in these preventable cancers, the need for screening and early detection is increasing. Examples of success in screening programmes can be seen in the cytological screening for cervical cancer in Scandinavian countries.
20 Jul 2012
Dr Clement Adebamowo talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about the lack of knowledge and literature on the topic of breast cancer in Africa.
?
Only in the last decade has epidemiological data on breast cancer in Africa been published.?Many cases in African countries present in women around the age of 40, where as cases in more developed countries present around 50 or 60.
?
This disparity has many clinical, social and psychological effects; however, the number of incidences is not higher in Africa. Research also suggest that cultural attitudes towards obesity and smoking need to change.
?
In addition, Dr Adebamowo notes that there is a need to increase the priority of screening and mammography, as well as the creation of regional centres for treatment.
20 Jul 2012
Brian Hook talks to ecancer at the 2012 National Cancer Institute Directors Meeting in Lyon about the launch of the Pink Ribbon Red Ribbon Partnership.
?
The partnership, which was launched in September 2011, aims to use the platform and structures of the Red Ribbon, HIV/AIDS, campaign to screen for women?s cancers.
?
Breast and cervical cancer are both connected to HIV and as many women overcome the difficulties of HIV, they are later dying of cancer.?Hook says that the platform exists with the ability to integrate the screening process for both diseases.
?
After starting in September 2011, the partnership announced the first country where the programme would launch in December. The programme currently operates in Zambia and Botswana with many more to come.
?
Hook also discusses the political, social and economical issues that the partnership aims to tackle in the coming years.
Source: http://ecancer.org/tv/pubdate/1591
matthew mcconaughey to catch a predator davenport chris hansen ehlers danlos syndrome the closer michael turner
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.